Literature DB >> 11453606

Physiologic changes in pregnancy and their effect on drug disposition.

M C Frederiksen1.   

Abstract

Changes in maternal physiology occur normally during pregnancy and have the potential to alter the absorption, distribution, and elimination of drugs used therapeutically in pregnant women. These physiologic changes include: plasma volume expansion and increases in extracellular fluid space and total body water; decreased plasma albumin concentration; a compensated respiratory alkalosis; increased cardiac output with regional blood flow changes; increased renal blood flow associated with increased glomerular filtration; changes in hepatic drug metabolizing enzymes; and changes in gastrointestinal function. These changes begin in early gestation but are most pronounced in the third trimester of pregnancy. Further maternal physiologic changes occur intrapartum with some normalizing themselves within 24 hours of delivery, while others are sustained only returning to normal some 12 weeks postpartum. These physiologic changes form the basis for the need for pharmacokinetic studies during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453606     DOI: 10.1053/sper.2001.24565

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  45 in total

1.  Plasma levels of oral risperidone during enteral nutrition in a pregnant schizophrenic patient.

Authors:  Giovanni Oriolo; Lucila Barbosa; Maria Luisa Imaz; Luisa Garcia; Sergi Borrego; Eduard Parellada
Journal:  Ther Adv Psychopharmacol       Date:  2015-04

2.  Hematological and serum biochemical profile values in pregnant and non-pregnant mares.

Authors:  Babak Faramarzi; Lon J Rich; Jolan Wu
Journal:  Can J Vet Res       Date:  2018-10       Impact factor: 1.310

3.  Pharmacotherapy and pregnancy: highlights from the Second International Conference for Individualized Pharmacotherapy in Pregnancy.

Authors:  David M Haas; Mary F Hebert; Offie P Soldin; David A Flockhart; Parvaz Madadi; James J Nocon; Christina D Chambers; Gary D Hankins; Shannon Clark; Katherine L Wisner; Lang Li; Jamie L Renbarger; Lee A Learman
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

4.  Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women.

Authors:  P Villani; M Floridia; M F Pirillo; M Cusato; E Tamburrini; A F Cavaliere; G Guaraldi; C Vanzini; A Molinari; A degli Antoni; M Regazzi
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

Review 5.  Anatomical and physiological alterations of pregnancy.

Authors:  Jamil M Kazma; John van den Anker; Karel Allegaert; André Dallmann; Homa K Ahmadzia
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-02-06       Impact factor: 2.745

6.  Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women.

Authors:  Amita Gupta; Grace Montepiedra; Lisa Aaron; Gerhard Theron; Katie McCarthy; Sarah Bradford; Tsungai Chipato; Tichaona Vhembo; Lynda Stranix-Chibanda; Carolyne Onyango-Makumbi; Gaerolwe R Masheto; Avy Violari; Blandina T Mmbaga; Linda Aurpibul; Ramesh Bhosale; Vidya Mave; Vanessa Rouzier; Anneke Hesseling; Katherine Shin; Bonnie Zimmer; Diane Costello; Timothy R Sterling; Nahida Chakhtoura; Patrick Jean-Philippe; Adriana Weinberg
Journal:  N Engl J Med       Date:  2019-10-03       Impact factor: 91.245

Review 7.  Maternal-fetal transport of hypoglycaemic drugs.

Authors:  Facundo Garcia-Bournissen; Denice S Feig; Gideon Koren
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

8.  Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel.

Authors:  Amita Gupta; Jyoti S Mathad; Susan M Abdel-Rahman; Jessica D Albano; Radu Botgros; Vikki Brown; Renee S Browning; Liza Dawson; Kelly E Dooley; Devasena Gnanashanmugam; Beatriz Grinsztejn; Sonia Hernandez-Diaz; Patrick Jean-Philippe; Peter Kim; Anne D Lyerly; Mark Mirochnick; Lynne M Mofenson; Grace Montepiedra; Jeanna Piper; Leyla Sahin; Radojka Savic; Betsy Smith; Hans Spiegel; Soumya Swaminathan; D Heather Watts; Amina White
Journal:  Clin Infect Dis       Date:  2015-12-09       Impact factor: 9.079

9.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

10.  Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth.

Authors:  Noriaki Washino; Yasuaki Saijo; Seiko Sasaki; Shizue Kato; Susumu Ban; Kanae Konishi; Rie Ito; Ayako Nakata; Yusuke Iwasaki; Koichi Saito; Hiroyuki Nakazawa; Reiko Kishi
Journal:  Environ Health Perspect       Date:  2008-11-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.